Re-Import of Heparin for Therapeutic Use
This key economic indicator for the Pharmaceutical sector has been recently updated.
- Argentina Re-Import of Heparin for Therapeutic Use grew 110.6% in 2019, compared to a year earlier.
- Since 2014 Australia Re-Import of Heparin for Therapeutic Use jumped by 309.1% year on year to $1,253,862.5.
- In 2019 Canada was ranked number 1 in Re-Import of Heparin for Therapeutic Use.
Top Countries in Re-Import of Heparin for Therapeutic Use
# | 9 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
---|---|---|---|---|---|---|
1 |
#1
Canada
|
1,738,281.50 | 2019 | +72.9 % | +112.5 % | View data |
2 |
#2
Australia
|
1,253,862.50 | 2019 | +10.8 % | +309.1 % | View data |
3 |
#3
China
|
676,088.00 | 2019 | -4.6 % | -3.9 % | View data |
4 |
#4
France
|
378,030.03 | 2019 | -14.2 % | -8.6 % | View data |
5 |
#5
Argentina
|
282,142.75 | 2019 | +110.6 % | -13.7 % | View data |
6 |
#6
New Zealand
|
40,139.76 | 2019 | +27.3 % | +60.2 % | View data |
7 |
#7
United Kingdom
|
5,416.76 | 2019 | -88.3 % | -13.2 % | View data |
8 |
#8
South Africa
|
62.84 | 2018 | NA | NA | View data |
9 |
#9
Thailand
|
26.36 | 2018 | -52.3 % | -47.1 % | View data |
Source: United Nations Statistical Office